Use of big data for drug development and for public and personal health and care

Genetic Epidemiology

Volumn 41, Issue 1, 2017, Pages 51-60

  Leyens, Lada ^a   Reumann, Matthias ^a,b   Malats, Nuria ^c   Brand, Angela ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b IBM RESEARCH ZURICH   (Switzerland)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

bioinformatics; cognitive computing; comparative effectiveness research, knowledge visualization; data commons; drug development; health policy; health systems; healthcare; personalized medicine; public health; public health genomics; safety monitoring; structured data; unstructured data

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; DRUG MONITORING; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; LIMIT OF QUANTITATION; PATIENT CARE; PRACTICE GUIDELINE; TELECOMMUNICATION; TREATMENT OUTCOME; DECISION MAKING; DRUG DEVELOPMENT; GENOMICS; INFORMATION PROCESSING; PERSONALIZED MEDICINE; PUBLIC HEALTH; UTILIZATION;

DATASETS AS TOPIC; DECISION MAKING; DELIVERY OF HEALTH CARE; DRUG DISCOVERY; GENOMICS; HUMANS; PRECISION MEDICINE; PUBLIC HEALTH;

EID: 85005925841     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.22012     Document Type: Article

References (43)

1. Belle, A., Thiagarajan, R., Soroushmehr, S. M., Navidi, F., Beard, D. A., & Najarian, K. (2015). Big data analytics in healthcare. BioMed Research International, 2015: 370194. doi: 10.1155/2015/370194. Epub 2015 Jul 2.
2. Bhatt, A. (2010). Evolution of clinical research: A history before and beyond james lind. Perspective Clinical Research, 1(1), 6–10.
3. Boyle, J. (2013). Biology must develop its own big-data systems. Nature, 499(7456), 7.
4. Broniatowski, D. A., Paul, M. J., & Dredze, M. (2014). Twitter: Big data opportunities. Science, 345(6193), 148–149.
5. Chiolero, A. (2013). Big data in epidemiology: Too big to fail? Epidemiology, 24(6), 938–939.
6. Davies, M., von Cavallar, S., Wyres, K. L., Reumann, M., Sepulveda, M., & Rogers, P. (2014). Intuitive information and knowledge representation of disease incidence and respective intervention strategies. Studies in Health Technology and Informatics, 205, 1173–1177. doi 10.3233/978-1-61499-432-9-1173
7. European Commission. (2015). http://ec.europa.eu. Retrieved from http://ec.europa.eu/justice/data-protection/review/index_en.htm (accessed August 12, 2015).
8. European Health Forum Gastein. Big data workshop. Workshop report, Gastein: European Health Forum Gastein, 2013.
9. FDA. (2014). open.fda.gov. Retrieved from https://open.fda.gov/drug/event/ (accessed August 12, 2015).
10. Feldman, S, Burghard, C., Hanover, J, & Schubmehl, D. (2012). Unlocking the power of unstructured data. IDC Health Insights, #HI235064, 1–10.
11. Frischmann, B. M., Madison, M. J., & Strandburg, K. J. (2014). Governing knowledge commons. Oxford: Oxford University Press.
12. Garrett, A., O'Kelly, M., Walp, D., & Berry, N. S. (2015). Lifecycle modeling and simulation in clinical trials. Applied Clinical Trials, 24(6).
13. Gotz, D., Wang, F., & Perer, A. (2014). A methodology for interactive mining and visual analysis of clinical event patterns using electronic health record data. Journal of Biomedical Informatics, 48, 148–159.
14. Hafen, E., Kossmann, D., & Brand, A. (2014). Health data cooperatives—citizen empowerment. Methods of Information in Medicine, 53(2), 82–86.
15. Herasevich, V., Pieper, M. S., Pulido, J., & Gajic, O. (2011). Enrollment into a time sensitive clinical study in the critical care setting: Results from computerized septic shock sniffer implementation. Journal of the American Medical Informatics Association, 18(5), 639–644.
16. Horgan, D., Jansen, M., Leyens, L., Lal, J. A., Sudbrack, R., Hackenitz, E., … Brand, A. (2014). An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe. Public Health Genomics, 17, 287–298.
17. Huang, Z., Dong, W., Ji, L., Gan, C., Lu, X., & Duan, H. (2014). Discovery of clinical pathway patterns from event logs using probabilistic topic models. Journal of Biomedical Informatics, 47, 39–57.
18. IBM. (2014). Mayo clinic and IBM task watson to improve clinical trial research. http://www-03.ibm.com/. Retrieved from http://www-03.ibm.com/press/us/en/pressrelease/44754.wss (accessed August 12, 2015).
19. Jalali, A, Olabode, O. A., & Bell, C. M. (2012). Leveraging cloud computing to address public health disparities: An analysis of the SPHPS. Online Journal of Public Health Information, 4(3): ojphi.v4i3.4325.
20. Jordan, M. I., & Mitchell, T. M. (2015). Machine learning: Trends, perspectives, and prospects. Science, 349(6245), 255–260.
21. Köpcke, F., & Prokosch, H-U. (2014). Employing computers for the recruitment into clinical trials: A comprehensive systematic review. Journal of Medical Internet Research, 16(7), e161.
22. Lehrach, H. (2015). Virtual clinical trials, an essential step in increasing the effectiveness of the drug development process. Public Health Genomics, 18(6), 366–371
23. Leyens, L., & Brand, A. (2016). Early patient access to medicines: Health technology assessment bodies need to catch up with new marketing authorization methods. Public Health Genomics, 19, 187–191.
24. Leyens, L., Richer, E., Mellien, Ø., Ballensiefen, W., & Brand, A. (2015). Available tools to facilitate early patient access to medicines in the EU and the USA: Analysis of conditional approvals and the implications for personalized medicine. Publich Health Genomics, 18(5), 249–259.
25. Martin-sanchez, F., & Verspoor, K. (2014). Big data in medicine is driving big change. Yearbook of medical informatics, 9, 14–20.
26. Milinovich, G. J., Soares Magalhaes, R. J., & Hu, W. (2015). Role of big data in the early detection of ebola and other emerging infectious diseases. Lancet, 3, e20–e21.
27. Nature. (2013). The big challenges of big data. Nature, 498, 255.
28. O'Donnovan, J., & Bersin, A. (2015). Controlling Ebola through mHealth strategies. Lancet, 3, e22.
29. Ola, O., & Sedig, K. (2014). The challenge of big data in public health: An opportunity for visual analytics. Online Journal of Public Health Informatics, 5(3), e223.
30. PatientsLikeMe. (2015). http://blog.patientslikeme.com. PatientsLikeMe and the FDA Sign Research Collaboration Agreement. Retrieved from http://blog.patientslikeme.com/2015/06/15/patientslikeme-and-the-fda-sign-research-collaboration-agreement/ (accessed August 12, 2015).
31. Perer, A., Wang, F., & Hu, J. (2015). Mining and exploring care pathways from electronic medical records with visual analytics. Journal of Biomedical Informatics, 56, 369–378.
32. PerMed 2020, CSA. (2015). The PerMed SRIA: ‘Shaping Europe's vision for personalised medicine. Koeln (Cologne): German Aerospace Center (DLR).
33. Raghupathi, W., & Raghupathi, V. (2014). Big data analytics in healthcare: Promise and potential. Health Information Science and Systems, 2, 3.
34. Sage Bionetworks. (2015). www.synapse.org. Retrieved from https://www.synapse.org/#!Synapse:sYn2580853/ (accessed August 12, 2015).
35. Sanger, F., & Coulson, A. R. (1975). A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. Journal of Molecular Biology, 94(3), 441–448.
36. Science Europe. (2014). How to transform big data into better health: envisioning a health big data ecosystem for advancing biomedical research and improving health outcomes in Europe. Workshop report, Brussels: Science Europe.
37. Sun, J., Wang, F., Hu, J., & Edabollahi, S. (2012). ACM. SIGKDD Explorations, 14(1), 16–24.
38. Szezák, N., Evers, M., Wang, J., & Pérez, L. (2014). The role of big data and advanced analytics in drug discovery, development, and commercialization. Clinical Pharmacology and Therapeutics, 95(5), 492–495.
39. The Economist. (2015). Medicine by numbers. The Economics Technology Quarterly, Mar 7th, 2015, 19–20.
40. Wang, L. W., Qu, A. P., Yuan, J. P., Chen, C., Sun, S. R., & Hu, M. B. (2013). Computer-based image studies on tumor nests mathematical features of breast cancer and their clinical prognostic value. PLoS One, 8(12), e82314.
41. Wetterstrand, K. A. (2015). DNA sequencing costs: Data from the NHGRI genome sequencing program (GSP). Retrieved from. http://www.genome.gov/sequencingcosts/ (accessed August 12, 2015).
42. Wyres, K. L., Conway, T. C., Garg, S., Queiroz, C., Reumann, M., Hogg, G., … Rusu, L. I. (2014).WGS analysis and interpretation in clinical and public health microbiology laboratories: What are the requirements and how do existing tools compare? Pathogens, 3(2), 437–458.
43. Zhang, S., Li, L., Yu, Y., Sun, X., Xu, L., Zhao, W., … Pan, Y. (2013). A novel approach to generating CER hypotheses based on mining clinical data. Studies in Health Technology and Informatics, 192, 991.